.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Julphar
Harvard Business School
Dow
AstraZeneca
Cantor Fitzgerald
McKesson
Federal Trade Commission
Healthtrust

Generated: December 13, 2017

DrugPatentWatch Database Preview

EPIRUBICIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Epirubicin Hydrochloride patents expire, and when can generic versions of Epirubicin Hydrochloride launch?

Epirubicin Hydrochloride is a drug marketed by Actavis Totowa, Akorn Inc, Cipla Ltd, Ebewe Pharma, Fresenius Kabi Oncol, Fresenius Kabi Usa, Hisun Pharm Hangzhou, Hospira, Impax Labs Inc, Mustafa Nevsat, Mylan Institutional, Mylan Labs Ltd, and West-ward Pharms Int. and is included in fourteen NDAs.

The generic ingredient in EPIRUBICIN HYDROCHLORIDE is epirubicin hydrochloride. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epirubicin hydrochloride profile page.
Drug patent expirations by year for EPIRUBICIN HYDROCHLORIDE

Pharmacology for EPIRUBICIN HYDROCHLORIDE

Medical Subject Heading (MeSH) Categories for EPIRUBICIN HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
HospiraEPIRUBICIN HYDROCHLORIDEepirubicin hydrochlorideINJECTABLE;IV (INFUSION)050807-002Sep 15, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Labs LtdEPIRUBICIN HYDROCHLORIDEepirubicin hydrochlorideINJECTABLE;INJECTION091599-002Mar 12, 2012APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntEPIRUBICIN HYDROCHLORIDEepirubicin hydrochlorideINJECTABLE;INJECTION065289-001Jun 27, 2007APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis TotowaEPIRUBICIN HYDROCHLORIDEepirubicin hydrochlorideINJECTABLE;INJECTION065445-001Sep 18, 2008APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraEPIRUBICIN HYDROCHLORIDEepirubicin hydrochlorideINJECTABLE;INJECTION065343-002Apr 19, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mustafa NevsatEPIRUBICIN HYDROCHLORIDEepirubicin hydrochlorideINJECTABLE;INJECTION090266-002Apr 15, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ebewe PharmaEPIRUBICIN HYDROCHLORIDEepirubicin hydrochlorideINJECTABLE;INJECTION065339-001Dec 22, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Akorn IncEPIRUBICIN HYDROCHLORIDEepirubicin hydrochlorideINJECTABLE;INJECTION090163-001Jun 24, 2009APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaEPIRUBICIN HYDROCHLORIDEepirubicin hydrochlorideINJECTABLE;INJECTION065408-002Oct 15, 2007APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraEPIRUBICIN HYDROCHLORIDEepirubicin hydrochlorideINJECTABLE;INJECTION065343-004Apr 19, 2007APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Dow
Cantor Fitzgerald
Colorcon
Citi
Healthtrust
Express Scripts
Teva
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot